Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) - PubMed (original) (raw)

Randomized Controlled Trial

. 2018 May;27(5):637-643.

doi: 10.1007/s00787-017-1077-9. Epub 2017 Nov 8.

Affiliations

Randomized Controlled Trial

Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS)

Jill Leon et al. Eur Child Adolesc Psychiatry. 2018 May.

Abstract

Little is known about the natural history of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS). This study prospectively followed 33 children with PANDAS for up to 4.8 years (mean 3.3 ± 0.7 years) after enrollment in a 24-week randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin (IVIG) (N = 35). Fourteen of eighteen children randomized to placebo received open label IVIG 6 weeks after the blinded infusion, so follow-up results reported below largely reflect outcomes in a population of children who received at least one dose of IVIG. Telephone interviews with the parents of participants found that at the time of phone follow-up, 29 (88%) were not experiencing clinically significant obsessive-compulsive symptoms. During the interim period (6-57 months after entering the clinical trial), 24 (72%) had experienced at least one exacerbation of PANDAS symptoms, with a median of one exacerbation per child (range 1-12; interquartile range 0-3). A variety of treatment modalities, including antibiotics, IVIG, psychiatric medications, cognitive behavioral therapy, and others, were used to treat these exacerbations, and were often used in combination. The outcomes of this cohort are better than those previously reported for childhood-onset OCD, which may support conceptualization of PANDAS as a subacute illness similar to Sydenham chorea. However, some children developed a chronic course of illness, highlighting the need for research that identifies specific symptoms or biomarkers that can be used to predict the longitudinal course of symptoms in PANDAS.

Keywords: Longitudinal study; PANDAS; Parent interview; Pediatric OCD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Front Psychiatry. 2017 Jan 19;8:3 - PubMed
    1. Acta Psychiatr Scand. 2004 Jul;110(1):4-13 - PubMed
    1. J Child Adolesc Psychopharmacol. 2015 Feb;25(1):26-30 - PubMed
    1. J Trop Pediatr. 1993 Jun;39(3):192-3 - PubMed
    1. J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):528-33 - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources